Digital Health, Technology & Innovation

EDDA Technology Named to TIME’s Top HealthTech Companies 2025

EDDA Technology, a global leading provider in advanced imaging-guided precision treatment solutions, announced its recognition on TIME’s inaugural list of the World’s Top HealthTech Companies 2025 developed in partnership with Statista Inc., a leading provider of data and industry rankings. EDDA Technology was recognized in the Diagnostics category, reflecting the company’s innovative leadership in AI integrated digital platform and clinical solutions. https://time.com/7318020/worlds-top-healthtech-companies-2025/

The list highlights the most innovative and impactful organizations transforming Healthcare through technology. Companies were evaluated across three key dimensions: Financial Performance Metrics, Reputation Analysis, and Online Engagement. Out of thousands of HealthTech companies reviewed worldwide, only 400 were selected for their excellence in driving meaningful change in healthcare.

The IQQA® platform provides comprehensive 3D image analysis using MR and CT and has been used in over 120,000 cases worldwide for surgery and treatment with substantial time-saving. This exceptionally intuitive solution supports in-depth quantitative volumetry with fast, dependable results and allows for versatility of transplantation, resection, or interventional procedure planning and post operative assessment.

“IQQA® is a proven innovation to support physicians in providing individualized and optimized treatment solution. Powered by our precision 3D capabilities, IQQA® aims to facilitate the next generation of precision surgery and treatment,” said Dr. Jianzhong Qian, President and CEO of EDDA Technology. “We’re honored EDDA Technology has been selected by TIME on the list for 2025 demonstrating our AI powered innovation. Moving forward, we are actively expanding our enabling digital platform to advance intelligent robotic solutions for precision surgery.”

Related posts

Neutron Therapeutics, Helsinki Treat First Cancer Patients with BNCT

PR Newswire

Turn Therapeutics Achieves 24-Hour Live Vaccine Stability

Business Wire

PCI Pharma Acquires Ajinomoto Althea to Boost US Aseptic Filling

Business Wire